ARTICLE VI COVENANTS AND AGREEMENTS
(c) Notwithstanding anything to the contrary in this Agreement, at any time prior to obtaining the Company Stockholder Approval, in the event that the Company receives a Competing Proposal from any Person or group of Persons, (i) the Company and its Representatives may contact such Person to clarify the terms and conditions thereof and (ii) the Company, the Company Board and their respective Representatives may engage in negotiations or discussions with, or furnish any information and other access to, any Person or group of Persons making such Competing Proposal and any of its Representatives or potential sources of financing if the Company Board determines in good faith (after consultation with its legal counsel and financial advisors) that such Competing Proposal either constitutes a Superior Proposal or would reasonably be expected to result in a Superior Proposal; provided that (x) prior to furnishing any material non-public information concerning the Company or its Subsidiaries, the Company receives from such Person or group, to the extent that such Person or group is not already subject to a confidentiality agreement with the Company, an executed confidentiality agreement containing customary confidentiality terms, it being understood that such confidentiality agreement need not contain a standstill provision or otherwise restrict the making, or amendment, of a Competing Proposal (and related communications) to the Company or the Company Board (such confidentiality agreement, an “Acceptable Confidentiality Agreement”) and (y) any such material non-public information so furnished in writing shall be promptly made available to Parent to the extent that it was not previously made available to Parent or its Representatives. For the avoidance of doubt, none of (A) the determination, in itself with no further action, by the Company Board that a Competing Proposal either constitutes a Superior Proposal or would reasonably be expected to result in a Superior Proposal or (B) the public disclosure, in itself, of such determination will constitute an Adverse Board Recommendation Change or violate this Section 6.5.
【参考訳】(c) 本契約にかかわらず、CompanyがCompany Stockholder Approvalを取得する前のいかなる時点でも、CompanyがPersonまたはPersonグループからCompeting Proposalを受け取った場合、(i) Companyおよびその代表者は、当該Competing Proposalの条件を明確にするために当該Personと接触することができ、(ii) Company、Company Board、およびそれぞれの代表者は、当該Competing Proposalを行ったPersonまたはPersonグループおよびその代表者または資金調達の潜在的な源と交渉または討議し、情報や他のアクセスを提供することができます。ただし、(x) Companyまたはその子会社に関する重要な非公開情報を提供する前に、Companyが当該PersonまたはPersonグループから、Companyとはすでに機密保持契約を締結していない場合に、カスタマリーな機密保持条件を含む実施可能な機密保持契約（「承認可能な機密保持契約」という）を受け取ること、および(y) 当該書面で提供される当該重要な非公開情報が、以前にParentまたはその代表者に提供されていなかった場合は、PromptlyにParentに提供されるものとします。明確さのために述べておくと、(A) Company BoardがCompeting Proposalがスーペリア・プロポーザルを構成するか、またはスーペリア・プロポーザルの結果になりうると判断した場合、その判断そのものではさらなる行動は伴わず、(B) 当該判断の公開開示そのものは、Adverse Board Recommendation Changeを構成するものではなく、本セクション6.5を違反するものとはなりません。
